A Novel In Situ Dendritic Cell Vaccine Triggered by Rose Bengal Enhances Adaptive Antitumour Immunity
Dendritic cell- (DC-) based vaccination has emerged as a promising antitumour immunotherapy. However, overcoming immune tolerance and immunosuppression in the tumour microenvironment (TME) is still a great challenge. Recent studies have shown that Rose Bengal (RB) can effectively induce immunogenic...
Saved in:
Main Authors: | Lanlin Zhang, Jiangyuan Du, Qian Song, Chufan Zhang, Xianghua Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/1178874 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overview of Cell Death Mechanisms Induced by Rose Bengal Acetate-Photodynamic Therapy
by: Elisa Panzarini, et al.
Published: (2011-01-01) -
Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity
by: Jurjen Tel, et al.
Published: (2016-01-01) -
The MicroRNA-106a/20b Strongly Enhances the Antitumour Immune Responses of Dendritic Cells Pulsed with Glioma Stem Cells by Targeting STAT3
by: Hui Zhou, et al.
Published: (2022-01-01) -
New Spectrophotometric and Conductometric Methods for Macrolide Antibiotics Determination in Pure and Pharmaceutical Dosage Forms Using Rose Bengal
by: Rania A. Sayed, et al.
Published: (2013-01-01) -
Utility of the Rose Bengal Test as a Point-of-Care Test for Human Brucellosis in Endemic African Settings: A Systematic Review
by: Abel B. Ekiri, et al.
Published: (2020-01-01)